100 Most Influential People in Healthcare - 2020

Facing a revenue cliff in the coming years as its blockbuster drug Humira loses patent protection, Gonzalez has looked for new ways to prop the business up. AbbVie closed its purchase of Botox-maker Allergan in May, making AbbVie the world’s fourth-largest drugmaker. It’s also eyeing new research to generate revenue, with a $30 million research alliance with Harvard University to develop new viral infection treatments and additional work on COVID-19 research.